Is Nuvation Bio Inc. (NUVB) a Buy, Sell, or Hold?
Nuvation Bio Inc.
NYSE:NUVB
$5.89 USD
-$0.01 (-0.17%)
- Volume
- 4.21M
- Average Volume
- 5.89M
- Market Capitalization
- $2.05B
- P/E Ratio
- -13.88
- Dividend Yield
- 0.00%
- Price Target
- $16.00
- Year High
- $9.75
- Year Low
- $2.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.44
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
36
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
34
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 3.1M
NUVB Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
NUVB Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2026-06-23 | M-Exempt | 1.87 | 2026-06-24 |
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2026-06-23 | M-Exempt | 1.74 | 2026-06-24 |
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2026-06-23 | M-Exempt | 1.74 | 2026-06-24 |
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2026-06-23 | M-Exempt | 1.87 | 2026-06-24 |
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2026-06-23 | S-Sale | 6.0255 | 2026-06-24 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-06-23 | M-Exempt | 2.93 | 2026-06-24 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-06-23 | M-Exempt | 2.93 | 2026-06-24 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-06-23 | S-Sale | 6.0189 | 2026-06-24 |
| Sauvage Philippe | officer: Chief Financial Officer | 2026-06-23 | M-Exempt | 2.17 | 2026-06-24 |
| Sauvage Philippe | officer: Chief Financial Officer | 2026-06-23 | M-Exempt | 2.17 | 2026-06-24 |
| Sauvage Philippe | officer: Chief Financial Officer | 2026-06-23 | S-Sale | 6.0076 | 2026-06-24 |
| Mashal Robert | director | 2026-06-09 | P-Purchase | 4.73 | 2026-06-11 |
| VERNON W ANTHONY | director | 2026-05-21 | A-Award | 4.79 | 2026-05-26 |
| Mashal Robert | director | 2026-05-21 | A-Award | 4.79 | 2026-05-26 |
| FALBERG KATHRYN E | director | 2026-05-21 | A-Award | 4.79 | 2026-05-26 |
| BLICKENSTAFF KIM D | director | 2026-05-21 | A-Award | 4.79 | 2026-05-26 |
| Bazemore Robert B | director | 2026-05-21 | A-Award | 4.79 | 2026-05-26 |
| Cui Xiangmin | director | 2026-05-21 | A-Award | 4.79 | 2026-05-26 |
| Cui Xiangmin | director | 2026-02-27 | A-Award | 5.91 | 2026-05-26 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-17 | M-Exempt | 2.93 | 2026-04-21 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-17 | M-Exempt | 2.93 | 2026-04-21 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-17 | S-Sale | 5.0144 | 2026-04-21 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | M-Exempt | 1.94 | 2026-04-21 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | M-Exempt | 1.94 | 2026-04-21 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2026-04-17 | S-Sale | 5.02 | 2026-04-21 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-06 | M-Exempt | 1.87 | 2026-04-08 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-06 | M-Exempt | 1.94 | 2026-04-08 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-06 | M-Exempt | 1.94 | 2026-04-08 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-06 | M-Exempt | 1.87 | 2026-04-08 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-04-06 | S-Sale | 4.5178 | 2026-04-08 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Makunje Moses | officer: SEE REMARKS | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Makunje Moses | officer: SEE REMARKS | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Sjogren Colleen | officer: Chief Commercial Officer | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Sauvage Philippe | officer: Chief Financial Officer | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Cui Xiangmin | director | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Hanley David C. | officer: CHIEF TECHNICAL OPERATIONS | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Hung David | director, 10 percent owner, officer: PRESIDENT AND CEO | 2026-02-27 | A-Award | 5.91 | 2026-03-03 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-12-01 | M-Exempt | 2.93 | 2025-12-03 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-12-01 | M-Exempt | 2.93 | 2025-12-03 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-12-01 | S-Sale | 7.8217 | 2025-12-03 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-25 | M-Exempt | 3.61 | 2025-11-26 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-26 | M-Exempt | 3.61 | 2025-11-26 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-26 | M-Exempt | 3.61 | 2025-11-26 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-25 | S-Sale | 7.5 | 2025-11-26 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-26 | S-Sale | 8 | 2025-11-26 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-11-20 | M-Exempt | 1.94 | 2025-11-24 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-11-20 | M-Exempt | 1.74 | 2025-11-24 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-11-20 | M-Exempt | 1.94 | 2025-11-24 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-11-20 | M-Exempt | 1.74 | 2025-11-24 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-11-20 | S-Sale | 7.227 | 2025-11-24 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-20 | M-Exempt | 1.87 | 2025-11-24 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-20 | M-Exempt | 1.87 | 2025-11-24 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-20 | S-Sale | 7.0037 | 2025-11-24 |
| Hanley David C. | officer: CHIEF TECHNICAL OPERATIONS | 2025-11-19 | M-Exempt | 1.87 | 2025-11-21 |
| Hanley David C. | officer: CHIEF TECHNICAL OPERATIONS | 2025-11-19 | M-Exempt | 1.87 | 2025-11-21 |
| Hanley David C. | officer: CHIEF TECHNICAL OPERATIONS | 2025-11-19 | S-Sale | 7.1384 | 2025-11-21 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-17 | M-Exempt | 1.87 | 2025-11-19 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-19 | M-Exempt | 1.87 | 2025-11-19 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-19 | M-Exempt | 1.87 | 2025-11-19 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-19 | S-Sale | 5.1035 | 2025-11-19 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-11-17 | S-Sale | 4.765 | 2025-11-19 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-10-27 | M-Exempt | 1.74 | 2025-10-29 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-10-27 | M-Exempt | 1.74 | 2025-10-29 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-10-27 | S-Sale | 5.0246 | 2025-10-29 |
| Mashal Robert | director | 2025-08-11 | G-Gift | 1.55 | 2025-08-13 |
| Mashal Robert | director | 2025-08-11 | G-Gift | 1.55 | 2025-08-13 |
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2025-06-18 | P-Purchase | 1.71 | 2025-06-18 |
| Sauvage Philippe | officer: Chief Financial Officer | 2025-06-17 | P-Purchase | 1.79 | 2025-06-18 |
| Sauvage Philippe | officer: Chief Financial Officer | 2025-06-16 | P-Purchase | 1.835 | 2025-06-18 |
| Sjogren Colleen | officer: Chief Commercial Officer | 2025-06-16 | P-Purchase | 1.807 | 2025-06-18 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2025-06-16 | P-Purchase | 1.8 | 2025-06-18 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2025-06-16 | P-Purchase | 1.79 | 2025-06-18 |
| Hung David | director, 10 percent owner, officer: PRESIDENT AND CEO | 2025-06-16 | P-Purchase | 1.787 | 2025-06-18 |
| FALBERG KATHRYN E | director | 2025-05-21 | A-Award | 2.03 | 2025-05-23 |
| VERNON W ANTHONY | director | 2025-05-21 | A-Award | 2.03 | 2025-05-23 |
| BLICKENSTAFF KIM D | director | 2025-05-21 | A-Award | 2.03 | 2025-05-23 |
| Mashal Robert | director | 2025-05-21 | A-Award | 2.03 | 2025-05-23 |
| Bazemore Robert B | director | 2025-05-21 | A-Award | 2.03 | 2025-05-23 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-05-02 | M-Exempt | 1.94 | 2025-05-06 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-05-02 | M-Exempt | 1.94 | 2025-05-06 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-05-02 | S-Sale | 2.5012 | 2025-05-06 |
| Hung David | director, 10 percent owner, officer: PRESIDENT AND CEO | 2025-04-07 | P-Purchase | 1.625 | 2025-04-08 |
| Hung David | director, 10 percent owner, officer: PRESIDENT AND CEO | 2025-04-04 | P-Purchase | 1.6636 | 2025-04-08 |
| Mashal Robert | director | 2025-04-01 | P-Purchase | 1.6699 | 2025-04-03 |
| Mashal Robert | director | 2025-04-01 | P-Purchase | 1.6655 | 2025-04-03 |
| Wentworth Kerry | officer: CHIEF REGULATORY OFFICER | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Sjogren Colleen | officer: Chief Commercial Officer | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Sauvage Philippe | officer: Chief Financial Officer | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Markel Stacy | officer: CHIEF PEOPLE OFFICER | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Makunje Moses | officer: SEE REMARKS | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Liu Dongfang | officer: CHIEF MEDICAL OFFICER | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Hung David | director, 10 percent owner, officer: PRESIDENT AND CEO | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Hattersley Gary | officer: CHIEF SCIENTIFIC OFFICER | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Hanley David C. | officer: CHIEF TECHNICAL OPERATIONS | 2025-02-28 | A-Award | 1.97 | 2025-03-04 |
| Wang Junyuan Jerry | director, officer: CEO, ANHEART THERAPEUTICS LTD. | 2024-11-11 | S-Sale | 2.89 | 2024-11-13 |
| Mashal Robert | director | 2024-10-08 | P-Purchase | 2.2 | 2024-10-10 |